Finance entity

Citigroup

Company C

Sentiment skews less negative than the wider beat, at 6% negative against 26% across all 4444 Finance stories in the same window. Coverage clusters in markets, which accounts for 13 of those 17, with the remainder spread across 4 other categories.

Last mentioned: Sep 9, 2026

Entity pulse

Recent coverage · Citigroup

17 stories
5.4 avg impact
12% positive
6% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 6 percentage points.

  • 12% positive
  • 82% neutral
  • 6% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Citigroup

Sentiment skews less negative than the wider beat, at 6% negative against 26% across all 4444 Finance stories in the same window. Coverage clusters in markets, which accounts for 13 of those 17, with the remainder spread across 4 other categories. Of the tracked stories, 7 of 17 also mention Weiss Ratings, the most common co-covered peer. That works out to roughly 0.6 stories per week across a 201-day span. The busiest single day carried 2. They are less corroborated than the beat average, carrying 2.2 original sources each against 2.7 for the same window. Their average consequence score of 5.4 runs below the beat's 6.2 for that window. This profile follows 17 Finance stories mentioning Citigroup across the period from February 21, 2026 to September 9, 2026.

Stories tracked
17
Per week
0.6
Negative
6%
Sources per story
2.2

Computed from the 17 stories linked to this entity, with beat comparisons drawn from all 4444 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Citigroup. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Eaton Shares Rise 2.8%

    Shares trade as high as $430.25 and last at $422.2780, closing above the 50-day and 200-day moving averages.

  2. Morgan Stanley and Weiss Ratings Turn Constructive

    Morgan Stanley raises its Eaton target to $520 from $500 and Weiss Ratings upgrades the stock from hold to buy.

  3. Wall Street Zen Downgrades Eaton

    Wall Street Zen lowers Eaton from buy to hold, diverging from the broader bullish consensus.

  4. Benchmark cuts BKKT target

    Benchmark reduced its Bakkt price target from $19.00 to $12.00 while maintaining a buy rating.

  5. Bakkt reports quarterly results

    Bakkt announced EPS of $1.94 and revenue of $170.15 million, missing revenue consensus of $373.27 million.

  6. Wall Street Zen downgrades to Hold

    Wall Street Zen cut both Klaviyo and Oceaneering International from Buy to Hold in Saturday research notes.

  7. Citigroup lifts KVYO target

    Citigroup raised its Klaviyo price target from $34.00 to $36.00 with a Buy rating.

  8. Cantor Fitzgerald raises DEI target

    Cantor Fitzgerald raised its Douglas Emmett target price from $12.00 to $13.00 with a neutral rating.

  9. KVYO analyst revisions

    Stephens, BTIG, Stifel, and Truist adjusted price targets on Klaviyo following earnings.

  10. Klaviyo Q2 earnings

    Klaviyo reported EPS of $0.19, meeting consensus, and revenue of $370.58 million.

  11. Douglas Emmett reports earnings

    Douglas Emmett reported quarterly EPS of negative $0.02.

  12. Multiple Analyst Target Raises

    RBC raises target to $512, BMO to $487, Citigroup to $485, and Sanford C. Bernstein reiterates outperform on Eaton.

  13. Eaton Reports Q2 Earnings

    Eaton reports EPS of $3.15, surpassing consensus estimates of $3.08 by $0.07.

  14. OII insider sale

    SVP Christopher J. Dyer sold 1,200 OII shares at an average price of $47.65 for $57,180.

  15. Weiss upgrades OII

    Weiss Ratings raised OII from Buy (B-) to Buy (B).

  16. Barclays lifts OII target

    Barclays increased its OII price objective from $39.00 to $47.00 with an Equal Weight rating.

  17. Weiss Ratings upgrades DEI

    Weiss Ratings upgraded Douglas Emmett from a sell (d) rating to a sell (d+) rating.

  18. Scotiabank raises DEI target

    Scotiabank raised its Douglas Emmett target price from $12.00 to $13.00 with a sector perform rating.

  19. Weiss Ratings upgrades BKKT

    Weiss Ratings upgraded Bakkt from a sell (e+) rating to a sell (d-) rating.

  20. Citigroup raises OII target

    Citigroup raised its Oceaneering target from $35.00 to $40.00 with a Neutral rating.

Stories mentioning Citigroup 17

Markets Neutral

Bakkt's $341M Market Cap Gets Hold Upgrade; Revenue Misses by 54%

Wall Street Zen's sell-to-hold upgrade for Bakkt comes as the stock trades at $7.66 with a $341.53 million market cap. The move follows a 54% revenue miss and a director's $783,000 insider buy, leaving analysts divided on whether this is a bottom or a value trap.

2 sources
Earnings Neutral

JPMorgan's $21.2B Profit Leads Big Bank Q2 Beat: What Investors Need to Know

Five of America's largest banks shattered earnings expectations for Q2 2026, led by JPMorgan Chase's historic $21.2 billion profit. A confluence of high interest rates, robust trading, and a surge in dealmaking drove the record profits, while stable consumer credit capped loan losses. Investors are now eyeing Morgan Stanley's upcoming report and potential regulatory tailwinds for sustained momentum.

3 sources

Source: wlac.iheart.com · kwhn.iheart.com

Markets Neutral

Industrial and Financial Sectors Retreat as Macro Headwinds Pressure Key Tickers

A synchronized downturn across industrial supply chains and the banking sector has pulled shares of WESCO, Commercial Vehicle Group, Park-Ohio, and Citigroup lower. The broad-based decline suggests a shift in market sentiment regarding manufacturing demand and credit stability amid evolving macroeconomic conditions.

4 sources

Source: markets.financialcontent.com · markets.financialcontent.com

Markets Neutral

AxoGen Surges as Wells Fargo Issues Rare 'Strong-Buy' Rating Upgrade

AxoGen (NASDAQ: AXGN) has received a major boost from Wall Street as Wells Fargo upgraded the nerve-repair specialist to a 'Strong-Buy' rating. The upgrade follows a significant price target hike from Jefferies, signaling a robust consensus on the company's growth potential in the medical technology sector.

2 sources

Citigroup is linked from 17 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.